IL-6ファミリーサイトカインは、ポドサイトにおいて共通してSTAT3を活性化させるが、リガンド特異的な作用を示す

  • 光岡 小百合
    大阪大・院薬・臨床薬効解析学
  • 尾花 理徳
    大阪大・院薬・臨床薬効解析学 大阪大・先導的学際研究機構生命医科学融合フロンティア研究部 大阪大・院医・国際医工情報センター 大阪大・放射線科学基盤機構附属ラジオアイソトープセンター
  • 三宅 芳明
    大阪大・院薬・臨床薬効解析学
  • 山本 彩葉
    大阪大・院薬・臨床薬効解析学
  • 田中 翔大
    大阪大・院薬・臨床薬効解析学
  • 前田 真貴子
    大阪大・院薬・臨床薬理学
  • 岡田 欣晃
    大阪大・院薬・臨床薬効解析学
  • 藤尾 慈
    大阪大・院薬・臨床薬効解析学 大阪大・先導的学際研究機構生命医科学融合フロンティア研究部

書誌事項

タイトル別名
  • IL-6 family cytokines, STAT3 activators, exhibit differential effects in a ligand-specific manner in podocytes

抄録

<p>[Background] </p><p>IL-6 family cytokines play protective roles in cardiomyocytes via STAT3 activation. Glomerular podocytes, as an important component of the kidney blood filtration, are terminally differentiated cells as well as cardiomyocytes. Although some studies have shown that STAT3 activation is associated with podocyte dysfunction, it remains unclear whether activated STAT3 exhibits differential functions depending on cytokines. The aim of this study is to assess the effects of IL-6 family cytokines/STAT3 signaling in podocytes. </p><p>[Methods and results] </p><p>To examine the pathophysiological relevance of IL-6 family cytokines in kidney diseases, C57BL/6J mice were subjected to ischemia-reperfusion or lipopolysaccharide (LPS) treatment. Quantitative PCR demonstrated that the expression level of IL-6, leukemia inhibitory factor (LIF) and IL-11 was upregulated in injured kidneys. In cultured podocytes, STAT3 was rapidly activated in response to the stimulation with IL-6, LIF or IL-11. Interestingly, LIF and IL-11 treatment suppressed H2O2-induced cell death in cultured podocytes, whereas IL-6 tended to increase cell death. </p><p>[Conclusion]</p><p>STAT3 could differentially function in an activator cytokine-specific manner, in podocytes, providing the important information for the development of therapy targeting STAT3 for kidney diseases.</p>

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ